Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Integrin

  • You have access
    Millettocalyxin B Inhibits Migratory Behavior of Lung Cancer Cells via Integrin α5 Suppression
    PENNAPA LAFAUY, ARNON SILAPECH, NITHIKOON AKSORN, BOONCHOO SRITULARAK and PITHI CHANVORACHOTE
    Anticancer Research August 2021, 41 (8) 3843-3849; DOI: https://doi.org/10.21873/anticanres.15177
  • You have access
    DS-1 Inhibits Migration and Invasion of Non-small-cell Lung Cancer Cells Through Suppression of Epithelial to Mesenchymal Transition and Integrin β1/FAK Signaling
    HARDYANTI EKA PUTRI, BOONCHOO SRITULARAK and PITHI CHANVORACHOTE
    Anticancer Research June 2021, 41 (6) 2913-2923; DOI: https://doi.org/10.21873/anticanres.15073
  • You have access
    Acyclic Retinoid Combined With Tenascin-C-derived Peptide Reduces the Malignant Phenotype of Neuroblastoma Cells Through N-Myc Degradation
    KAZUKI OTSUKA, MANABU SASADA, YU HIRANO, YUSUKE NOHARA, TAKUYA IYODA, YOSHIKAZU HIGAMI, HIROAKI KODAMA and FUMIO FUKAI
    Anticancer Research July 2019, 39 (7) 3487-3492; DOI: https://doi.org/10.21873/anticanres.13494
  • You have access
    Integrin as a Molecular Target for Anti-cancer Approaches in Lung Cancer
    NITHIKOON AKSORN and PITHI CHANVORACHOTE
    Anticancer Research February 2019, 39 (2) 541-548; DOI: https://doi.org/10.21873/anticanres.13146
  • You have access
    Cycloartobiloxanthone Inhibits Migration and Invasion of Lung Cancer Cells
    SUCHARAT TUNGSUKRUTHAI, BOONCHOO SRITULARAK and PITHI CHANVORACHOTE
    Anticancer Research November 2017, 37 (11) 6311-6319;
  • You have access
    High αv Integrin Level of Cancer Cells Is Associated with Development of Brain Metastasis in Athymic Rats
    YINGJEN JEFFREY WU, MICHAEL A. PAGEL, LESLIE L. MULDOON, RONGWEI FU and EDWARD A. NEUWELT
    Anticancer Research August 2017, 37 (8) 4029-4040;
  • You have access
    Cilengitide and Cetuximab Reduce Cytokine Production and Colony Formation of Head and Neck Squamous Cell Carcinoma Cells Ex Vivo
    GUNNAR WICHMANN, SUSAN CEDRA, DAPHNE SCHLEGEL, MARLEN KOLB, SUSANNE WIEGAND, ANDREAS BOEHM, MATHIAS HOFER and ANDREAS DIETZ
    Anticancer Research February 2017, 37 (2) 521-527;
  • You have access
    Dendrofalconerol A Suppresses Migrating Cancer Cells via EMT and Integrin Proteins
    PREMKAMOL PENGPAENG, BOONCHOO SRITULARAK and PITHI CHANVORACHOTE
    Anticancer Research January 2015, 35 (1) 201-205;
  • You have access
    Cisplatin at Sub-toxic Levels Mediates Integrin Switch in Lung Cancer Cells
    ARNATCHAI MAIUTHED and PITHI CHANVORACHOTE
    Anticancer Research December 2014, 34 (12) 7111-7117;
  • You have access
    Ouabain Mediates Integrin Switch in Human Lung Cancer Cells
    CHUANPIT NINSONTIA and PITHI CHANVORACHOTE
    Anticancer Research October 2014, 34 (10) 5495-5502;
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire